United Therapeutics CEO Martine Rothblatt reports disposal of 9,406 common shares worth $4.64 million - UTHR News | RalliesUnited Therapeutics CEO Martine Rothblatt reports disposal of 9,406 common shares worth $4.64 million
U
UTHR• CEO share transaction details
- United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at $135.42 on Sept. 2, 2026.
- The trust sold 8,496 shares on the same day at weighted-average prices ranging from $477.70 to $510.05.
- Trust holdings ended at 324,443 shares following the reported transactions.
